Table 4.
Odds ratio of prevalent osteopenia or osteoporosis according to a 1 − SD increase in ucOC and BTMs in the men and women.
| Variables | Men (n = 411) | Women (n = 468) | ||||||
|---|---|---|---|---|---|---|---|---|
| Unadjusted | Adjusted | Unadjusted | Adjusted | |||||
| OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
| ucOC (ng/ml) | 1.46 (1.19, 1.80) | <0.001 | 1.63 (1.25, 2.13) | 0.004 | 1.07 (0.89, 1.29) | 0.461 | 1.70 (1.19, 2.42) | 0.004 |
| P1NP (ng/ml) | 1.27 (0.98, 1.65) | 0.071 | 1.55 (1.07, 2.30) | 0.019 | 3.91 (2.67, 5.73) | <0.001 | 2.47 (1.38, 4.45) | 0.003 |
| β-CTX (ng/ml) | 0.68 (0.54, 0.87) | 0.002 | 1.10 (0.87, 1.37) | 0.462 | 3.77 (2.76, 5.14) | <0.001 | 3.13 (1.92, 5.10) | <0.001 |
For the unadjusted models, ucOC, P1NP, and β-CTX were analyzed separately; for adjusted model, age, BMI, Cr, and 25OHD were adjusted.
ucOC, undercarboxylated osteocalcin; P1NP, procollagen type 1 N-propeptide; β-CrossLaps of type I collagen-containing cross-linked C-telopeptide; BMI, body mass index; Cr, creatinine; 25OHD, 25-hydroxyvitamin D.